Discovery of Clinical Candidate GDC-8264, a Novel, Potent and Selective RIP1 Inhibitor for Amelioration of Tissue Damage and the Treatment of Inflammatory Diseases
1. 系统已在2025-11-07 08:49:31对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c01891
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c01891
其他信息:
出版社: American Chemical Society (ACS)
作者: Snahel Patel; Huifen Chen; Eugene Varfolomeev; Youngsu Kwon; Sreemathy Ramaswamy; Pawan Bir Kohli; John G. Quinn; Joshua D. Webster; Jialin Mao; Yuan Chen; Rina Fong; F. Esra Demircioglu; Patrick Lupardus; Craig Stivala; Gregory L. Hamilton; Michael Siu; Swathi Sujatha-Bhaskar; Vishnu Mohanan; Adeyemi O. Adedeji; Sara F. Santagostino; Jonathan Maher; Brent McKenzie; Michael E. Rothenberg; Adam Johnson; Domagoj Vucic
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c01891
